Filing Details

Accession Number:
0000711377-21-000017
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-27 14:26:38
Reporting Period:
2021-04-23
Accepted Time:
2021-04-27 14:26:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1188987 A Terri Morrical No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-04-23 1,121 $62.70 38,696 No 4 M Direct
Common Stock Disposition 2021-04-26 1,121 $96.97 37,575 No 4 S Direct
Common Stock Acquisiton 2021-04-26 800 $62.70 38,375 No 4 M Direct
Common Stock Disposition 2021-04-26 800 $97.09 37,575 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2021-04-23 1,121 $0.00 1,121 $62.70
Common Stock Common Stock (Right to Buy) Disposition 2021-04-26 800 $0.00 800 $62.70
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
88,879 2023-12-01 No 4 M Direct
88,079 2023-12-01 No 4 M Direct
Footnotes
  1. Options were granted on 11/1/2018, have five year lives, and vest in equal annual 20% installments on each of the first five anniversary dates of the grant